FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

766045006: Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent (disorder)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3660593011 Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660594017 Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660595016 Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660596015 A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbour unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3660597012 A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbor unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3660593011 Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660594017 Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660595016 Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660596015 A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbour unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3660597012 A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbor unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3385541001000118 Akute myeloische Leukämie und myelodysplastische Syndrome durch alkylierende Agenzien de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
983171000172118 leucémie aigüe myéloïde et syndromes myélodysplasiques liés aux agents alkylants fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
983171000172118 leucémie aigüe myéloïde et syndromes myélodysplasiques liés aux agents alkylants fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3385541001000118 Akute myeloische Leukämie und myelodysplastische Syndrome durch alkylierende Agenzien de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Causative agent (attribute) Alkylating agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Associated morphology Therapy-related acute myeloid leukemia and myelodysplastic syndrome, alkylating agent-related type false Inferred relationship Existential restriction modifier (core metadata concept) 1
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Is a Complication of procedure false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Is a séquelle false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent After Administration of antineoplastic agent true Inferred relationship Existential restriction modifier (core metadata concept) 2
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Due to Administration of antineoplastic agent true Inferred relationship Existential restriction modifier (core metadata concept) 3
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Finding site Bone marrow structure true Inferred relationship Existential restriction modifier (core metadata concept) 1
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Is a Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Is a trouble causé par un médicament false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Is a Complication of chemotherapy (disorder) false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Is a Disorder following clinical procedure false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Is a Complication of introduction procedure false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Is a Drug-induced lesion false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Is a Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder) true Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent Associated morphology Myeloid neoplasm post cytotoxic therapy (morphologic abnormality) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Component annotation with string value reference set (foundation metadata concept)

Back to Start